New education center opens at University of Minnesota Duluth
College of Pharmacy gets new home
NACDS counters New York Times article
NACDS debunks New York Times article, "The 'Poisonous Cocktail' of Multiple Drugs"
Class-action AWP suits awaiting final settlements
Inflated average wholesale prices issued by two publishers have resulted in high costs for consumers, who have filed class-action suits against them.
DEA classifies oripavine as Schedule II
Oripavine is designated a Schedule II controlled substance by the Drug Enforcement Administration
NQF issues standards for substance abuse treatment
National Quality Forum releases standards for substance abuse treatment
On-line tool quantifies pain med usage
New on-line tool for calculating pain medication index
TWC Global recalls Axcil and Desirin supplements
TWC Global issues recall of Axcil and Desirin
Revision made to NCCN treatment guide for rare sarcoma
NCCN updates its dermatofibrosarcoma protuberans guidelines.
NCCN revises hepatobiliary cancer guide
NCCN updates hepatobiliary cancer treatment guidelines.
ASHP creates center for pharmacy workforce development
ASHP launches on-line resource center
CMS begins annual low-income subsidy reassessment
CMS outlines plans for contacting low-income subsidy beneficiaries for Medicare Part D program.
CVS/pharmacy to offer flu vaccinations
CVS/pharmacy to offer flu vaccinations in over 4,000 stores.
FDA warns about parasite in baby product
FDA warns about risk of Cryptosporidium illness from Baby's Bliss Gripe Water
Fla. pharmacist guilty in Internet scheme
Pharmacy owner pleads guilty to charges stemming from Affpower Internet pharmacy.
Minnesota hospitals not billing patients, insurers for errors
Hospitals swallowing cost of errors
Campath granted a regular approval by the FDA
Campath granted regular approval
New Reclast post-fracture study results released
New study results released for once-yearly Reclast (zoledronic acid) injection
Parkinson's disease drugmaker offers rebate to patients
Valeant Pharmaceuticals offers zelaCARD rebate program to Parkinson's disease patients.
Survey shows most Americans confident in safety of prescription drugs
Americans confident about drug safety
HHS releases department-wide report on personalized medicine
Personalized medicine report issued by HHS
New agency study to look at cardiovascular risk of ADHD drugs
Study from AHRQ and FDA will examine cardiovascular risks of ADHD drugs.
PhRMA study claims Part D benefits uninsured
A PhRMA-sponsored study claims Medicare Part D reduced expenses for beneficiaries who had no insurance prior to the program.
NACDS member testifies before Senate on methamphetamine
NACDS testifies to Senate on methamphetamine
FDA warns P&G about unlawful marketing of Vicks Early Defense
Although FDA is not aware of significant health risks, the agency is concerned about some of the product's claims.
Community pharmacy groups advocate Medicaid issues to lawmakers
More than 70 pharmacy executives and representatives visited with members of Congress.
CIGNA launches new on-line Rx price quote tool
Age range for FluMist expanded
FDA approves expanded age range for FluMist influenza vaccine.
Walgreens tops drugstore Web site survey
Walgreens web site tops Rite Aid and CVS in an independent survey from Consumer Reports' HealthRating.org
Lower dose of carisoprodol gets FDA nod
New dose of carisoprodol (Soma) is approved for MedPointe Pharmaceuticals
SERM gets FDA nod for breast cancer
Raloxifene (Evista, Lilly) is approved for breast cancer
